Infectious Conjunctivitis

Okogen announced completion of $3.3 million in financing to advance the company through its phase 2b clinical program for acute infectious conjunctivitis, as well as support development of an AI-driven image evaluation platform.

Amidst the flurry of safety guidance provided for both health care professionals and citizens regarding COVID-19, the American Optometric Association’s Health Policy Institute provided specific guidance for eye care providers.